Ropolivy

FH

F. Hoffmann-La Roche Ltd

Manufacturer · Finished Dosage FormsSwitzerland

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Injectables & Parenterals / Large Volume Parenterals (LVP)/IV Infusions

Trade Type

Sell

Product Name

Ropolivy

Details

Polatuzumab vedotin

Substance

Polatuzumab vedotin

Manufacturer(s)

BSP Pharmaceuticals S.p.A - Italy

Registered Market

Viet Nam

Specifications

Dosage Form: Powder for reconstitution as solution concentrate for reconstitution as solution injection/infusion
Packaging: Box 1 vial
Strength: 140mg
Standards: In-house standard
Shelf Life: 30 month

Documents

Drug Marketing Authorization Number

Document No.: 800410646024

Issue Date: Jul 30, 2024

Expiry Date: Jul 30, 2027

Note: 547/QĐ/QLD | 51

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product